Chapter

Oncology

pp 1482-1496

Nausea and Vomiting in the Cancer Patient

  • Paula GillAffiliated withDivision of Surgery Oncology, Department of Surgery, University of MichiganDepartment of Oncology, Mayo Clinic Foundation
  • , Axel GrotheyAffiliated withDivision of Surgery Oncology, Department of Surgery, University of MichiganDivision of Medical Oncology, Mayo Clinic Foundation
  • , Charles LoprinziAffiliated withDivision of Surgery Oncology, Department of Surgery, University of MichiganDivision of Medical Oncology, Mayo Clinic Foundation

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curable treatments. Despite the availability of more than 20 different antiemetics, nausea and vomiting in cancer patients remain problematic and continue to pose tremendous challenges to practicing oncologists.